Literature DB >> 12934939

Genetic modification of xenografts.

J L Platt1.   

Abstract

For nearly a century, xenotransplantation has been seen as a potential approach to replacing organs and tissues damaged by disease. Until recently, however, the application of xenotransplantation has seemed only a remote possibility. What has changed this perspective is the advent of genetic engineering of large animals; that is, the ability to add genes to and remove genes from lines of animals that could provide an enduring source of tissues and organs for clinical application. Genetic engineering could address the immunologic, physiologic and infectious barriers to xenotransplantation, and could allow xenotransplantation to provide a source of cells with defined and even controlled expression of exogenous genes. This communication will consider one perspective on the application of genetic engineering in xenotransplantation.

Mesh:

Substances:

Year:  2003        PMID: 12934939      PMCID: PMC1350600          DOI: 10.1007/978-3-642-55541-1_1

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  90 in total

1.  Knocking out xenograft rejection.

Authors:  Jeffrey L Platt
Journal:  Nat Biotechnol       Date:  2002-03       Impact factor: 54.908

Review 2.  Tissue engineering--current challenges and expanding opportunities.

Authors:  Linda G Griffith; Gail Naughton
Journal:  Science       Date:  2002-02-08       Impact factor: 47.728

Review 3.  Xenotransplantation and other means of organ replacement.

Authors:  M Cascalho; J L Platt
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

Review 4.  Transplantation of embryonic organs - kidney and pancreas.

Authors:  Marc R Hammerman
Journal:  Am J Transplant       Date:  2004       Impact factor: 8.086

Review 5.  Fusion of approaches to the treatment of organ failure.

Authors:  Brenda Ogle; Marilia Cascalho; Jeffrey L Platt
Journal:  Am J Transplant       Date:  2004       Impact factor: 8.086

6.  Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs.

Authors:  Yifan Dai; Todd D Vaught; Jeremy Boone; Shu-Hung Chen; Carol J Phelps; Suyapa Ball; Jeff A Monahan; Peter M Jobst; Kenneth J McCreath; Ashley E Lamborn; Jamie L Cowell-Lucero; Kevin D Wells; Alan Colman; Irina A Polejaeva; David L Ayares
Journal:  Nat Biotechnol       Date:  2002-03       Impact factor: 54.908

Review 7.  Genetic therapies and xenotransplantation.

Authors:  Brenda M Ogle; Jeffrey L Platt
Journal:  Expert Opin Biol Ther       Date:  2002-03       Impact factor: 4.388

8.  Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation.

Authors:  Hideo Nagata; Masahiro Ito; Jin Cai; Albert S Edge; Jeffrey L Platt; Ira J Fox
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

9.  Production of alpha 1,3-galactosyltransferase-deficient pigs.

Authors:  Carol J Phelps; Chihiro Koike; Todd D Vaught; Jeremy Boone; Kevin D Wells; Shu-Hung Chen; Suyapa Ball; Susan M Specht; Irina A Polejaeva; Jeff A Monahan; Pete M Jobst; Sugandha B Sharma; Ashley E Lamborn; Amy S Garst; Marilyn Moore; Anthony J Demetris; William A Rudert; Rita Bottino; Suzanne Bertera; Massimo Trucco; Thomas E Starzl; Yifan Dai; David L Ayares
Journal:  Science       Date:  2002-12-19       Impact factor: 47.728

10.  Human and porcine early kidney precursors as a new source for transplantation.

Authors:  Benjamin Dekel; Tatyana Burakova; Fabian D Arditti; Shlomit Reich-Zeliger; Oren Milstein; Sarit Aviel-Ronen; Gideon Rechavi; Nir Friedman; Naftali Kaminski; Justen H Passwell; Yair Reisner
Journal:  Nat Med       Date:  2002-12-23       Impact factor: 53.440

View more
  1 in total

1.  Barriers to the successful treatment of liver disease by hepatocyte transplantation.

Authors:  Kyle A Soltys; Alejandro Soto-Gutiérrez; Masaki Nagaya; Kevin M Baskin; Melvin Deutsch; Ryotaro Ito; Benjamin L Shneider; Robert Squires; Jerry Vockley; Chandan Guha; Jayanta Roy-Chowdhury; Stephen C Strom; Jeffrey L Platt; Ira J Fox
Journal:  J Hepatol       Date:  2010-06-30       Impact factor: 25.083

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.